Cromatic
Summary
Cromatic is revolutionizing the R&D domain by launching a digital platform specifically designed to optimize the outsourced R&D ecosystem. This platform facilitates a marketplace connecting vetted Contract Research Organizations (CROs) with biotech and pharmaceutical companies and offers an integrated dashboard for comprehensive project management. This dashboard encompasses functionalities for project onboarding, billing and payments, status monitoring, data analysis, milestone tracking, and facilitates streamlined communication across projects. Cromatic’s solution addresses the industry’s pervasive challenges, including the difficulty in accessing detailed CRO information, misalignment of expectations leading to expensive outcomes, lack of effective project management tools, and inconsistent data formatting across multiple projects.
Cromatic is founded by CEO Ann Lin, a Stanford PhD and biotech entrepreneur, and CTO Anne Chen, a former software engineer at Meta.
Why we invested
- Exceptional young, hungry team with pedigree.
- Large market with limited competition.
- Strong investor syndicate
Investors
Team
Ann Lin CEO/Cofounder
Ann previously co-founded – and currently advises – Meliora Therapeutics, a venture leveraging AI to develop precision oncology medication. Ann earned her bachelor’s degree in Biochemistry and Economics from Stony Brook University. She has since been a Fulbright Scholar and received her PhD in Genetics from Stanford University.Ann has also been recognized by Forbes on the ‘30 under 30’ list in 2020.
Anne Chen CTO/Cofounder
Anne brings valuable experience from her time at Meta, where she was a Software Engineer and early member of the Facebook Dating engineering team. Furthermore, Anne previously co-founded and led technical operations for OpenChefs and OpenMeal. She received her bachelor’s degree in computer science from CalTech.
